(BUFS) BUFS - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
BUFS: Options, Exchange-traded, Contracts, Settlement, ETFs, Portfolio
The BUFS ETF employs a laddered portfolio strategy, meaning it invests in a series of underlying ETFs with staggered target outcome periods. These expiration dates are structured on a rolling basis, allowing the fund to maintain exposure to market movements while managing the timing of its investments. The underlying ETFs allocate most of their assets to FLEX Options on the iShares Russell 2000 ETF (IWM), which provides exposure to small-cap U.S. equities. FLEX Options are highly customizable, exchange-traded contracts with guaranteed settlement by the Options Clearing Corporation (OCC), offering a level of security and flexibility in hedging or speculation.
As a non-diversified fund, BUFS can concentrate its investments in a smaller number of securities, which may amplify both potential returns and risks. This approach aligns with its defined outcome strategy, which seeks to deliver specific return profiles within predefined periods. The funds structure is designed to appeal to investors seeking targeted exposure to small-cap equities with the added layer of options-based risk management.
Additional Sources for BUFS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BUFS ETF Overview
Market Cap in USD | 70m |
Category | Defined Outcome |
IPO / Inception | 2024-05-29 |
BUFS ETF Ratings
Growth 5y | 29.2% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -4.54 |
Analysts | - |
Fair Price Momentum | 17.26 USD |
Fair Price DCF | - |
BUFS Dividends
No Dividends PaidBUFS Growth Ratios
Growth Correlation 3m | -45.9% |
Growth Correlation 12m | 67.3% |
Growth Correlation 5y | 67.3% |
CAGR 5y | 2.67% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | 0.45 |
Alpha | -5.75 |
Beta | 0.65 |
Volatility | 12.77% |
Current Volume | 60.2k |
Average Volume 20d | 27.6k |
As of March 15, 2025, the stock is trading at USD 20.37 with a total of 60,226 shares traded.
Over the past week, the price has changed by -0.89%, over one month by -6.30%, over three months by -6.88% and over the past year by +2.67%.
Neither. Based on ValueRay Analyses, BUFS is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 29.20 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BUFS as of March 2025 is 17.26. This means that BUFS is currently overvalued and has a potential downside of -15.27%.
BUFS has no consensus analysts rating.
According to ValueRays Forecast Model, BUFS BUFS will be worth about 19.3 in March 2026. The stock is currently trading at 20.37. This means that the stock has a potential downside of -5.45%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 19.3 | -5.4% |